Official Publication of Allelopathy Books
Online:
NAAS Rating : 7.28, Indexed in SCOPUS (2021): SNIP : 0.378, SJR : 0.248,
Cite Score : 1.8, Google Scholar (2021) : h Index : 49, I 10index : 523, UGC Care List
Editor-in-Chief Prof. M. J. Reigosa, Spain
Published Bi-monthly with New Editorial Board
Faster Ms. Publication: 2-3 months after Submission
CORONA PANDEMIC 2020-2022
Since 2020, Corona Pandemic has almost stopped research in most countries. Thus, we received less Mss. during this period, hence, we have to reduce the Number of Mss. published in each Issue of Allelopathy Journal.
CALL FOR PAPERS : To overcome the adverse effects of Corona Pandemic on your Research Group. Please advise your contact/ Friend Researchers to submit their Research Papers to Allelopathy Journal for its survival.
EXPANDED SCOPE OF ALLELOPATHY JOURNAL FROM 2023
The Allelopathy refers to any process involving secondary metabolites produced by plants, microorganisms, viruses and fungi that influence the growth and development of Agricultural and Biological Systems (International Allelopathy Society, 1996). The definition includes plants and animals (till now we published Mss related to Agriculture and Biological Sciences). Although since the start of Journal (1994), we received Mss. related to Human Health Sciences but were rejected. Now due to development of increased resistance of Human pathogens to Antibiotics, Medical Researchers are testing New secondary metabolites from plants to overcome this problem. Thus, since 2021, we are seriously considering to expand the Scope of Journal by including the Health Sciences. In 2021 and 2022, we published 5- Mss. related to Health Sciences. Now from 2023, Allelopathy Journal will also Publish Mss. related to Health sciences in following fields: Human Pathogens etc., hence, research papers are also invited from Health Sciences.
Please wait ! while loading...